Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal
Journal of Neurogastroenterology and Motility
;
: 341-348, 2017.
Artigo
em Inglês
| WPRIM
| ID: wpr-184086
ABSTRACT
Irritable bowel syndrome is a group of functional gastrointestinal disorders with not yet fully clarified etiology. Recent evidence suggesting that mast cells may play a central role in the pathogenesis of irritable bowel syndrome paves the way for agents targeting histamine receptors as a potential therapeutic option in clinical treatment. In this review, the role of histamine and histamine receptors is debated. Moreover, the clinical evidence of anti-histamine therapeutics in irritable bowel syndrome is discussed.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Receptores Histamínicos
/
Histamina
/
Síndrome do Intestino Irritável
/
Gastroenteropatias
/
Mastócitos
Idioma:
Inglês
Revista:
Journal of Neurogastroenterology and Motility
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS